Shanghai Hile Bio-tech (603718) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.001x

Based on the latest financial reports, Shanghai Hile Bio-tech (603718) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.18 Million ≈ $-173.40K USD) by net assets (CN¥1.70 Billion ≈ $248.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603718 net asset quality score to measure how much of total assets are equity-financed.

Shanghai Hile Bio-tech - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Shanghai Hile Bio-tech's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shanghai Hile Bio-tech cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Shanghai Hile Bio-tech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Hile Bio-tech ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Korea No. 9 Special Purpose Acquisition Co. Ltd. KQ:368770	0.092x
Bangkok Land Public Company Limited BK:BLAND-R	0.003x
Huaiji Dengyun Auto-parts Holding Co Ltd SHE:002715	0.037x
TWFG, Inc. Class A Common Stock NASDAQ:TWFG	0.051x
Shanghai Kaytune Industrial Co.Ltd SHE:301001	N/A
Hangzhou Xili Intelligent Technology Co. Ltd. A SHG:688616	0.060x
Shanghai Lisheng Racing Co Ltd SHE:002858	0.016x
ZheJiang BangJie Digital Knitting Share Co Ltd SHE:002634	-0.008x

Annual Cash Flow Conversion Efficiency for Shanghai Hile Bio-tech (2011–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Hile Bio-tech from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 603718 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥895.97 Million ≈ $131.11 Million	CN¥58.83 Million ≈ $8.61 Million	0.066x	+140.65%
2024-12-31	CN¥1.70 Billion ≈ $249.23 Million	CN¥46.47 Million ≈ $6.80 Million	0.027x	+1190.98%
2023-12-31	CN¥1.17 Billion ≈ $171.91 Million	CN¥-2.94 Million ≈ $-429.95K	-0.003x	-100.95%
2022-12-31	CN¥1.11 Billion ≈ $162.57 Million	CN¥292.91 Million ≈ $42.86 Million	0.264x	+496.48%
2021-12-31	CN¥987.19 Million ≈ $144.46 Million	CN¥43.63 Million ≈ $6.38 Million	0.044x	-74.64%
2020-12-31	CN¥962.20 Million ≈ $140.80 Million	CN¥167.68 Million ≈ $24.54 Million	0.174x	+191.93%
2019-12-31	CN¥992.57 Million ≈ $145.24 Million	CN¥59.25 Million ≈ $8.67 Million	0.060x	+223.68%
2018-12-31	CN¥1.03 Billion ≈ $150.10 Million	CN¥18.92 Million ≈ $2.77 Million	0.018x	-43.23%
2017-12-31	CN¥1.07 Billion ≈ $157.29 Million	CN¥34.92 Million ≈ $5.11 Million	0.032x	-69.87%
2016-12-31	CN¥1.01 Billion ≈ $147.11 Million	CN¥108.39 Million ≈ $15.86 Million	0.108x	-48.51%
2015-12-31	CN¥963.31 Million ≈ $140.96 Million	CN¥201.69 Million ≈ $29.51 Million	0.209x	+6.09%
2014-12-31	CN¥558.50 Million ≈ $81.73 Million	CN¥110.22 Million ≈ $16.13 Million	0.197x	-33.07%
2013-12-31	CN¥500.66 Million ≈ $73.26 Million	CN¥147.63 Million ≈ $21.60 Million	0.295x	+12.64%
2012-12-31	CN¥467.89 Million ≈ $68.47 Million	CN¥122.48 Million ≈ $17.92 Million	0.262x	-29.01%
2011-12-31	CN¥405.74 Million ≈ $59.37 Million	CN¥149.61 Million ≈ $21.89 Million	0.369x	--

About Shanghai Hile Bio-tech

SHG:603718 China Biotechnology

Market Cap

$275.69 Million

CN¥1.88 Billion CNY

Market Cap Rank

#15250 Global

#4500 in China

Share Price

CN¥2.89

Change (1 day)

+0.00%

52-Week Range

CN¥2.61 - CN¥7.61

All Time High

CN¥51.09